OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production within Chinese hamster ovary (CHO) cells is a paramount challenge with the biopharmaceutical industry. Various strategies can be employed maximize antibody titer, including process parameter optimization, genetic engineering, and implementation of perfusion processes. Fine-tuning growth paramete